Grape King Bio Statistics
Total Valuation
Grape King Bio has a market cap or net worth of TWD 21.04 billion. The enterprise value is 18.34 billion.
Market Cap | 21.04B |
Enterprise Value | 18.34B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | Jun 20, 2024 |
Share Statistics
Grape King Bio has 148.14 million shares outstanding. The number of shares has increased by 0.08% in one year.
Shares Outstanding | 148.14M |
Shares Change (YoY) | +0.08% |
Shares Change (QoQ) | -0.24% |
Owned by Insiders (%) | 13.02% |
Owned by Institutions (%) | 21.60% |
Float | 113.90M |
Valuation Ratios
The trailing PE ratio is 14.90.
PE Ratio | 14.90 |
Forward PE | n/a |
PS Ratio | 1.94 |
PB Ratio | 2.20 |
P/FCF Ratio | 20.69 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.27, with an EV/FCF ratio of 18.03.
EV / Earnings | 12.91 |
EV / Sales | 1.69 |
EV / EBITDA | 6.27 |
EV / EBIT | 7.42 |
EV / FCF | 18.03 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 1.69.
Current Ratio | 1.36 |
Quick Ratio | 1.14 |
Debt / Equity | 1.69 |
Debt / EBITDA | 0.06 |
Debt / FCF | 0.18 |
Interest Coverage | 829.69 |
Financial Efficiency
Return on equity (ROE) is 20.01% and return on invested capital (ROIC) is 14.14%.
Return on Equity (ROE) | 20.01% |
Return on Assets (ROA) | 10.04% |
Return on Capital (ROIC) | 14.14% |
Revenue Per Employee | 21.67M |
Profits Per Employee | 2.84M |
Employee Count | 501 |
Asset Turnover | 0.71 |
Inventory Turnover | 3.00 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.09% in the last 52 weeks. The beta is 0.47, so Grape King Bio's price volatility has been lower than the market average.
Beta (5Y) | 0.47 |
52-Week Price Change | -8.09% |
50-Day Moving Average | 142.86 |
200-Day Moving Average | 152.85 |
Relative Strength Index (RSI) | 48.76 |
Average Volume (20 Days) | 206,186 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Grape King Bio had revenue of TWD 10.86 billion and earned 1.42 billion in profits. Earnings per share was 9.53.
Revenue | 10.86B |
Gross Profit | 8.49B |
Operating Income | 2.44B |
Pretax Income | 2.62B |
Net Income | 1.42B |
EBITDA | 2.85B |
EBIT | 2.44B |
Earnings Per Share (EPS) | 9.53 |
Balance Sheet
The company has 4.18 billion in cash and 183.48 million in debt, giving a net cash position of 4.00 billion or 26.99 per share.
Cash & Cash Equivalents | 4.18B |
Total Debt | 183.48M |
Net Cash | 4.00B |
Net Cash Per Share | 26.99 |
Equity (Book Value) | 10.87B |
Book Value Per Share | 64.64 |
Working Capital | 1.41B |
Cash Flow
In the last 12 months, operating cash flow was 1.63 billion and capital expenditures -615.57 million, giving a free cash flow of 1.02 billion.
Operating Cash Flow | 1.63B |
Capital Expenditures | -615.57M |
Free Cash Flow | 1.02B |
FCF Per Share | 6.86 |
Margins
Gross margin is 78.16%, with operating and profit margins of 22.51% and 13.09%.
Gross Margin | 78.16% |
Operating Margin | 22.51% |
Pretax Margin | 24.13% |
Profit Margin | 13.09% |
EBITDA Margin | 26.22% |
EBIT Margin | 22.51% |
FCF Margin | 9.37% |
Dividends & Yields
This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 4.93%.
Dividend Per Share | 6.90 |
Dividend Yield | 4.93% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 71.95% |
Buyback Yield | -0.08% |
Shareholder Yield | 4.85% |
Earnings Yield | 6.71% |
FCF Yield | 4.83% |
Stock Splits
The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.
Last Split Date | Sep 15, 2005 |
Split Type | Forward |
Split Ratio | 1.0205 |